Fed. Circ. Weighs Bid To Finish Off Pfizer Vaccine Patent
A Federal Circuit panel looked closely Thursday at a Patent Trial and Appeal Board decision that upheld one claim of a patent covering Pfizer's billion-dollar Prevnar 13 vaccine, posing tough questions...To view the full article, register now.
Already a subscriber? Click here to view full article